Um die volle Funktionalität der Webseite nutzen zu können, müssen Sie JavaScript in ihrem Browser aktivieren.

DAX24.239,10+1,04 %

Gold3.299,50-0,04 %

Öl (Brent)70,12+0,73 %

Dow Jones44.239,91-0,35 %

US Tech 10022.700,29+0,06 %

EUR/USD1,17236-0,01 %

Top 15 der gesamten Suchanfragen der letzten 7 Tage

Login

InMed Pharmaceuticals Registered Aktie

Aktie

ISIN: CA4576377002 WKN: A40UCN SYM: INM Land Flagge CA

Kanada

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

2,7450

USD

+0,92 %

+0,0250 USD

Letzter Kurs 08.07.25 NYSE

InMed Pharmaceuticals Registered Aktie kaufen

Geldkurs

08.07.25

2,6000

USD

200 STK

Briefkurs

08.07.25

2,8000

USD

100 STK

BEI SMARTBROKER+ HANDELN

Hinweis
Verlängerte Handelszeiten
Ab sofort von 07:30 bis 23:00 Uhr

Baader Tragding

Neueste Nachrichten

InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules 27.06.25 · newsfile · InMed Pharmaceuticals Registered
InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules 25.06.25 · newsfile · InMed Pharmaceuticals Registered
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study 24.06.25 · newsfile · InMed Pharmaceuticals Registered
InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA 13.06.25 · newsfile · InMed Pharmaceuticals Registered
ZEVASKYN Approval Positions Abeona as Emerging Player in Dystrophic Epidermolysis Bullosa Market \| DelveInsight 22.05.25 · PR Newswire (engl.) · Shionogi Seiyaku
InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update 13.05.25 · newsfile · InMed Pharmaceuticals Registered
InMed Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update 13.02.25 · newsfile · InMed Pharmaceuticals Registered
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration 03.02.25 · newsfile · InMed Pharmaceuticals Registered
InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds 22.01.25 · newsfile · InMed Pharmaceuticals Registered
InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a Long-Term Preclinical Alzheimer's Disease Study 21.01.25 · newsfile · InMed Pharmaceuticals Registered
InMed Announces Results of 2024 Annual General Meeting 19.12.24 · newsfile · InMed Pharmaceuticals Registered
InMed Enters Into Standby Equity Purchase Agreement 17.12.24 · newsfile · InMed Pharmaceuticals Registered

1
2

Meistgelesen

30 Tage
12 Monate

InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study 140 Leser
InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest ... 128 Leser
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under ... 120 Leser
InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq ... 108 Leser

InMed Pharmaceuticals Demonstrates INM-901 as an Oral Formulation Targeting Alzheimer's Disease 924 Leser
InMed Pharmaceuticals Strengthens Patent Portfolio with Issuance of Three U.S. Patents 200 Leser
ZEVASKYN Approval Positions Abeona as Emerging Player in Dystrophic Epidermolysis Bullosa Market \| ... 156 Leser
InMed's INM-901 Demonstrates Statistically Significant Reduction in Neuroinflammation in a ... 148 Leser
InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study 140 Leser
InMed Pharmaceuticals Announces Granting of Patent for Novel Compounds 132 Leser
InMed Pharmaceuticals Announces Favorable Behavioral Outcomes with INM-901 in Long-Term Preclinical ... 128 Leser
InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest ... 128 Leser
InMed Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update 124 Leser
InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under ... 120 Leser